United States, May 12 -- GE HealthCare unveiled SIGNA (TM) Sprint, an FDA 510(k) pending ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical and research areas.The need for advanced diagnostics in cardiology and oncology continues to grow, with cardiovascular disease accounting for 32% of global deaths, and cancer accounting for nearly 10 million deaths per year. Meeting this demand with advanced MRI technologies has the potential to make significant impact for cardiology and oncology patients.With the goal of delivering higher ...